Reactive Astrocytes in ALS Display Diminished Intron Retention
Overview
Authors
Affiliations
Reactive astrocytes are implicated in amyotrophic lateral sclerosis (ALS), although the mechanisms controlling reactive transformation are unknown. We show that decreased intron retention (IR) is common to human-induced pluripotent stem cell (hiPSC)-derived astrocytes carrying ALS-causing mutations in VCP, SOD1 and C9orf72. Notably, transcripts with decreased IR and increased expression are overrepresented in reactivity processes including cell adhesion, stress response and immune activation. This was recapitulated in public-datasets for (i) hiPSC-derived astrocytes stimulated with cytokines to undergo reactive transformation and (ii) in vivo astrocytes following selective deletion of TDP-43. We also re-examined public translatome sequencing (TRAP-seq) of astrocytes from a SOD1 mouse model, which revealed that transcripts upregulated in translation significantly overlap with transcripts exhibiting decreased IR. Using nucleocytoplasmic fractionation of VCP mutant astrocytes coupled with mRNA sequencing and proteomics, we identify that decreased IR in nuclear transcripts is associated with enhanced nonsense mediated decay and increased cytoplasmic expression of transcripts and proteins regulating reactive transformation. These findings are consistent with a molecular model for reactive transformation in astrocytes whereby poised nuclear reactivity-related IR transcripts are spliced, undergo nuclear-to-cytoplasmic translocation and translation. Our study therefore provides new insights into the molecular regulation of reactive transformation in astrocytes.
Age-Related Neurodegenerative Diseases: A Stem Cell's Perspective.
Calvo B, Schembri-Wismayer P, Duran-Alonso M Cells. 2025; 14(5).
PMID: 40072076 PMC: 11898746. DOI: 10.3390/cells14050347.
Hiew J, Lim Y, Liu H, Ng C Commun Biol. 2025; 8(1):347.
PMID: 40025162 PMC: 11873215. DOI: 10.1038/s42003-025-07790-w.
Ma B, Ren J, Qian X Bioengineering (Basel). 2025; 12(2).
PMID: 40001624 PMC: 11852053. DOI: 10.3390/bioengineering12020104.
Human VCP mutant ALS/FTD microglia display immune and lysosomal phenotypes independently of GPNMB.
Clarke B, Ziff O, Tyzack G, Petric Howe M, Wang Y, Klein P Mol Neurodegener. 2024; 19(1):90.
PMID: 39593143 PMC: 11590569. DOI: 10.1186/s13024-024-00773-1.
Towards an integrated approach for understanding glia in Amyotrophic Lateral Sclerosis.
Majewski S, Klein P, Boillee S, Clarke B, Patani R Glia. 2024; 73(3):591-607.
PMID: 39318236 PMC: 11784848. DOI: 10.1002/glia.24622.